Lawsuits Over Ozempic, Other GLP-1 Drugs: Are Label Warnings Adequate?

Product Liability / April 22, 2024 / 4 minutes of reading / By / , , , , , , ,

In recent years, millions of Americans have turned to medications like Ozempic, Wegovy, and Mounjaro, which belong to the class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RA), […]

Lawsuits Over Ozempic, Other GLP-1 Drugs: Are Label Warnings Adequate? Read More ยป